4-{[[(4-cyanophenyl)sulfonyl](pyridin-2-ylmethyl)amino]methyl}benzoic acid | 1191070-01-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-{[[(4-cyanophenyl)sulfonyl](pyridin-2-ylmethyl)amino]methyl}benzoic acid
• 英文别名: 4-[[(4-cyanophenyl)sulfonyl-(pyridin-2-ylmethyl)amino]methyl]benzoic acid
• CAS: 1191070-01-5
• 化学式: C₂₁H₁₇N₃O₄S
• 分子量: 407.45
• InChiKey: YVGSLMFBMGWZAW-UHFFFAOYSA-N

物化性质

• 沸点：
  665.7±65.0 °C(Predicted)
• 密度：
  1.45±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  29
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  120
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  4-{[[(4-cyanophenyl)sulfonyl](pyridin-2-ylmethyl)amino]methyl}benzoic acid 、 1-苯基环丙胺 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 生成 4-((4-cyano-N-(pyridin-2-ylmethyl)phenylsulfonamido)methyl)-N-(1-phenylcyclopropyl)benzamide
  参考文献：
  名称：

  Discovery of a novel series of CXCR3 antagonists

  摘要：

  The discovery of a novel series of CXCR3 antagonists is described. Starting from an HTS positive, iterative optimization gave potent compounds (IC(50) 15 nM in a chemotaxis assay). The strategy employed to improve the metabolic stability of these derivatives is described. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.04.113
• 作为产物：
  描述：

  methyl 4-{[[(4-cyanophenyl)sulfonyl](pyridin-2-ylmethyl)amino]methyl}benzoate 在 水 、 sodium hydroxide 作用下， 以 四氢呋喃 为溶剂， 生成 4-{[[(4-cyanophenyl)sulfonyl](pyridin-2-ylmethyl)amino]methyl}benzoic acid
  参考文献：
  名称：

  Discovery of a novel series of CXCR3 antagonists

  摘要：

  The discovery of a novel series of CXCR3 antagonists is described. Starting from an HTS positive, iterative optimization gave potent compounds (IC(50) 15 nM in a chemotaxis assay). The strategy employed to improve the metabolic stability of these derivatives is described. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.04.113

文献信息

• Sulfonamides
  申请人：Crosignani Stefano

  公开号：US20110028509A1

  公开（公告）日：2011-02-03

  The invention relates to compounds of formula I wherein R 1 , R 2 , R 4 , R a , R b , R c , R e , A*, W 1 , W 2 and W 3 are as defined in claim 16 , for the treatment of CXCR3 related diseases.

  该发明涉及式I的化合物，其中R1、R2、R4、Ra、Rb、Rc、Re、A*、W1、W2和W3的定义如权利要求16所述，用于治疗与CXCR3相关的疾病。
• SULFONAMIDES
  申请人：Merck Serono S.A.

  公开号：EP2265575A2

  公开（公告）日：2010-12-29
• [EN] SULFONAMIDES<br/>[FR] SULFONAMIDES
  申请人：MERCK SERONO SA

  公开号：WO2009124962A2

  公开（公告）日：2009-10-15

  The invention relates to compounds of formula (I) wherein R1, R2, R4, Ra, Rb, Rc, Re, A*, W1, W2 and W3 are as defined in claim 1, for the treatment of CXCR3 related diseases.
• Discovery of a novel series of CXCR3 antagonists
  作者：Stefano Crosignani、Marc Missotten、Christophe Cleva、Ruggero Dondi、Yann Ratinaud、Yves Humbert、Ashis Baran Mandal、Agnès Bombrun、Christine Power、André Chollet、Amanda Proudfoot

  DOI：10.1016/j.bmcl.2010.04.113

  日期：2010.6

  The discovery of a novel series of CXCR3 antagonists is described. Starting from an HTS positive, iterative optimization gave potent compounds (IC(50) 15 nM in a chemotaxis assay). The strategy employed to improve the metabolic stability of these derivatives is described. (C) 2010 Elsevier Ltd. All rights reserved.